1. Spironolactone Does Not Prevent Acute Mountain Sickness: A Prospective, Double- Blind, Randomized, Placebo-Controlled Trial by SPACE Trial Group (Spironolactone and Acetazolamide Trial in the Prevention of Acute Mountain Sickness Group) 
Buddha Basnyat, MD, MSc, FACP, FRCP (E), Peter S. Holck, PhD, Matiram Pun, MBBS, Stephen Halverson, MD, Piotr Szawarski, MD, Jeffrey Gertsch, MD, Mike Steif, EMT, Skip Powell, MD, Subhash Khanal, MBBS, Anip Joshi, MBBS, Ravi Shankar, Jamie Karambay, MS, Hattie D. Alexander, MD, Allyson Stone, MS, Candice Morrissey, MSPH, Beth H. Thompson, MD, Jeremy Farrar, BSc, MBBS, FRCP, DPhil, OBE 
Wilderness & Environmental Medicine 
Volume 22, Issue 1, Pages (March 2011)
DOI: /j.wem
Copyright © 2011 Wilderness Medical Society Terms and Conditions

2. Figure 1 Lobuje: study endpoint.
Wilderness & Environmental Medicine  , 15-22DOI: ( /j.wem )
Copyright © 2011 Wilderness Medical Society Terms and Conditions

3. Figure 2 Study flow chart.
Wilderness & Environmental Medicine  , 15-22DOI: ( /j.wem )
Copyright © 2011 Wilderness Medical Society Terms and Conditions